TimeArticle
2 min agoMillerKnoll (MLKN) Q1 2027: Sales guide cut and core misses as demand softens
3 min agoAutoZone (AZO) Q4 2026: One-offs pad the margin as commercial and same-store sales slow
24 min agoThor Industries (THO) Q4 2026: Margins compress under supplier pricing power, explicit guidance withheld
52 min agoAbivax (ABVX) Q2 2026: Mega-raise secures runway, but Crohn's pipeline stalls
1 hr agoHere Group Limited (HERE) Q4 2026: Growth reverses and margins break as flagship toy brand fades
4 d agoUpexi (UPXI) Q4 2026: Balance sheet fortified, but asset volatility dictates the print
5 d agoInnate Pharma (IPHA) Q2 2026: Sobi deal solves the funding crisis, but sacrifices standalone upside
5 d agoLennar Corporation (LEN) Q3 2026: Broad misses across volume and price trigger another guide cut
5 d agoAeluma (ALMU) Q4 2026: Balance sheet secured, but core manufacturing model shifts
5 d agoIspire Technology (ISPR) Q4 2026: Growth returns on ODM ramp, but margins and cash timeline break
6 d agoLuxExperience (LUXE) Q4 2026: Turnaround assets flip to growth, SG&A cuts deliver margins
6 d agoTrip.com Group (TCOM) Q2 2026: International growth absorbed by macro friction and domestic reset
6 d agoEvolution Petroleum Corporation (EPM) Q4 2026: EBITDA doubles as Q3 weather passes, Permian royalty deal adds runway
6 d agoVera Bradley (VRA) Q2 2027: Direct channel accelerates, but wholesale collapse and H2 guide check momentum
7 d ago51Talk Online Education Group (COE) Q2 2026: Growth hits a wall as marketing efficiency takes priority
7 d agoForgent Power Solutions (FPS) Q4 2026: Record bookings and facility expansion answer the capacity ceiling concern
7 d agoBioceres Crop Solutions Corp. (BIOX) Q4 2026: Cost cuts return EBITDA to positive, balance sheet still stranded
7 d agoMindWalk Holdings Corp. (HYFT) Q1 2027: Facility removes dilution risk as platform pivot consumes margins
7 d agoRadiant Logistics (RLGT) Q4 2026: Ad-hoc volume drives growth, while structural freight recovery remains pending
7 d agoDave & Buster's (PLAY) Q2 2026: Entertainment weakness persists, driving severe margin deleverage
7 d agoKestra Medical Technologies (KMTS) Q1 2027: Margin leverage proves the model, but costs widen the burn

Scroll to Top